group-women-sports-teams

News & Media

Take a look inside our world

Press Releases



Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer



Teva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early Settlement



New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025



Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to Date



Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day



Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA



Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June



Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma



Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes



Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt


Feature stories


Teva scientists in Sydney, Australia working in the lab

2024 Healthy Future Report: Creating the Future We Want to See



Neurological Conditions Take So Much: Teva is Working to Give Something Back


Colleagues standing in a small group discussing something while laughing. Two of the women are holding notebooks.

Diversity: A Superpower in Shaping Tomorrow’s Therapies at Teva Pharmaceuticals



Coming Home to Teva: Rediscovering Purpose and Community


little boys hugging smiling

Spreading HOPE: Teva’s Work to Improve Global Access to Medicine


Woman using inhaler device for asthma

Medical Device Engineering: the Teva Story


Dr Beatrice Wiafe Addai addressing breast cancer meeting in Ghana

Behind the Numbers: Working to Tackle Breast Cancer in Ghana


Mark DeStefano, Director of Global Technology Innovation for the CPD R&D group at Teva

3 Trends I’m Watching in Drug Delivery Devices


Beryl Ojwang, MD, MBA, MPH, Global Associate Medical Director in Neuroscience, shares how technology helps generate patient insights for Teva scientists.

“AI helps us better understand and support patient needs”


Teva team outdoor

Teva Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index


Contacts for Media Inquiries

Grace Ann Arnold

North America

+1-973-2653670
GraceAnn.Arnold@tevapharm.com

Eden Klein

Israel & Corporate

+972-3-9062645
Eden.Klein@teva.co.il

Fiona Cohen

Europe

fiona.cohen@tevaeu.com


Teva Media Assets

These proprietary media assets are available for download and are intended for non-commercial media use and research only.

Download Logo Download Teva B-Roll


Connect with us on social media

Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Follow us on Twitter

Go to twitter.com